Citizens JMP raised the firm’s price target on Hippo (HIPO) to $40 from $35 and keeps an Outperform rating on the shares. The company reported strong Q2 results and achieved net income positivity for the first time, the analyst tells investors in a research note. The firm believes Hippo shares are attractively valued at current levels.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIPO: